Bernadette Broccolo counsels the full range of health and life science industry stakeholders on the transactional, strategic and regulatory dimensions of complex strategies for harnessing and deploying big data assets, artificial Intelligence and other digital health innovation discovery, commercialization and deployment; streamlining biomedical research and precision medicine; and generating alternative revenue streams. She regularly negotiates agreements for a wide spectrum of digital health innovation collaborations. The areas of concentration Bernadette skillfully applies to such engagements include privacy law and other digital health innovation compliance, health information technology acquisition transactions, health information network formation, collaboration transactions, corporate governance, and human subject research compliance. Chambers USA consistently recognizes Bernadette in its top tier rankings of health lawyers both nationally and in Illinois, and she is a frequent and prominent speaker and author in her areas of expertise, including her most recent contribution as Co-Editor in Chief and Co-Author of The Law of Digital Health, published by AHLA in March 2018.
Michael W. Peregrine represents corporations (and their officers and directors) in connection with the full range of governance and fiduciary duty matters, officer-director liability issues, charitable trust law and corporate structure. Michael is recognized as one of the leading national practitioners in corporate governance law, and is a senior contributor to Forbes.com, where his articles focus on governance and leadership topics.
Michael is outside governance counsel to many prominent corporations, including hospitals and health systems, voluntary health organizations, colleges and universities, social service agencies, health insurance companies, pharmaceutical companies and financial institutions.
Michael is also often called upon to advise boards in response to external/regulatory challenges to governance. He frequently serves as special counsel in connection with confidential internal board reviews and investigations.
The power and promise of artificial intelligence comes in a Pandora’s box full of novel and multi-dimensional enterprise risks—legal, regulatory, financial, operational, ethical and reputational—that go above and beyond those associated with other technology innovations.